P999: ERK1/2 INHIBITION REDUCES OSTEOPONTIN PLASMA LEVELS AND BONE MARROW FIBROSIS IN A MYELOFIBROSIS MOUSE MODEL

Bibliographic Details
Main Authors: S. Rontauroli, E. Bianchi, L. Tavernari, M. Dall’Ora, G. Grisendi, M. Mirabile, S. Sartini, E. Genovese, C. Carretta, S. Mallia, S. Parenti, L. Fabbiani, N. Bartalucci, L. Losi, M. Dominici, A. M. Vannucchi, R. Manfredini
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000846864.95333.42
_version_ 1797287189290156032
author S. Rontauroli
E. Bianchi
L. Tavernari
M. Dall’Ora
G. Grisendi
M. Mirabile
S. Sartini
E. Genovese
C. Carretta
S. Mallia
S. Parenti
L. Fabbiani
N. Bartalucci
L. Losi
M. Dominici
A. M. Vannucchi
R. Manfredini
author_facet S. Rontauroli
E. Bianchi
L. Tavernari
M. Dall’Ora
G. Grisendi
M. Mirabile
S. Sartini
E. Genovese
C. Carretta
S. Mallia
S. Parenti
L. Fabbiani
N. Bartalucci
L. Losi
M. Dominici
A. M. Vannucchi
R. Manfredini
author_sort S. Rontauroli
collection DOAJ
first_indexed 2024-03-07T18:29:21Z
format Article
id doaj.art-c421096f862a49debe236e8e5bb84d35
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T18:29:21Z
publishDate 2022-06-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-c421096f862a49debe236e8e5bb84d352024-03-02T06:40:52ZengWileyHemaSphere2572-92412022-06-01688989010.1097/01.HS9.0000846864.95333.42202206003-00889P999: ERK1/2 INHIBITION REDUCES OSTEOPONTIN PLASMA LEVELS AND BONE MARROW FIBROSIS IN A MYELOFIBROSIS MOUSE MODELS. Rontauroli0E. Bianchi1L. Tavernari2M. Dall’Ora3G. Grisendi4M. Mirabile5S. Sartini6E. Genovese7C. Carretta8S. Mallia9S. Parenti10L. Fabbiani11N. Bartalucci12L. Losi13M. Dominici14A. M. Vannucchi15R. Manfredini161 Centre for Regenerative Medicine, Life Sciences Department, University of Modena and Reggio Emilia, Modena1 Centre for Regenerative Medicine, Life Sciences Department, University of Modena and Reggio Emilia, Modena1 Centre for Regenerative Medicine, Life Sciences Department, University of Modena and Reggio Emilia, Modena2 Rigenerand S.R.L., Medolla (MO)3 Division of Oncology, Laboratory of Cellular Therapy, Department of Medical and Surgical Sciences of Children & Adults1 Centre for Regenerative Medicine, Life Sciences Department, University of Modena and Reggio Emilia, Modena1 Centre for Regenerative Medicine, Life Sciences Department, University of Modena and Reggio Emilia, Modena1 Centre for Regenerative Medicine, Life Sciences Department, University of Modena and Reggio Emilia, Modena1 Centre for Regenerative Medicine, Life Sciences Department, University of Modena and Reggio Emilia, Modena1 Centre for Regenerative Medicine, Life Sciences Department, University of Modena and Reggio Emilia, Modena1 Centre for Regenerative Medicine, Life Sciences Department, University of Modena and Reggio Emilia, Modena4 Department of Medical and Surgical Sciences of Children & Adults, Pathology Unit, University of Modena and Reggio Emilia, Modena5 Department of Experimental and Clinical Medicine, and Center Research and Innovation of Myeloproliferative Neoplasms (CRIMM), University of Florence, Careggi University Hospital, Florence6 Department of Life Sciences, Pathology Unit, University of Modena and Reggio Emilia, Modena, Italy3 Division of Oncology, Laboratory of Cellular Therapy, Department of Medical and Surgical Sciences of Children & Adults5 Department of Experimental and Clinical Medicine, and Center Research and Innovation of Myeloproliferative Neoplasms (CRIMM), University of Florence, Careggi University Hospital, Florence1 Centre for Regenerative Medicine, Life Sciences Department, University of Modena and Reggio Emilia, Modenahttp://journals.lww.com/10.1097/01.HS9.0000846864.95333.42
spellingShingle S. Rontauroli
E. Bianchi
L. Tavernari
M. Dall’Ora
G. Grisendi
M. Mirabile
S. Sartini
E. Genovese
C. Carretta
S. Mallia
S. Parenti
L. Fabbiani
N. Bartalucci
L. Losi
M. Dominici
A. M. Vannucchi
R. Manfredini
P999: ERK1/2 INHIBITION REDUCES OSTEOPONTIN PLASMA LEVELS AND BONE MARROW FIBROSIS IN A MYELOFIBROSIS MOUSE MODEL
HemaSphere
title P999: ERK1/2 INHIBITION REDUCES OSTEOPONTIN PLASMA LEVELS AND BONE MARROW FIBROSIS IN A MYELOFIBROSIS MOUSE MODEL
title_full P999: ERK1/2 INHIBITION REDUCES OSTEOPONTIN PLASMA LEVELS AND BONE MARROW FIBROSIS IN A MYELOFIBROSIS MOUSE MODEL
title_fullStr P999: ERK1/2 INHIBITION REDUCES OSTEOPONTIN PLASMA LEVELS AND BONE MARROW FIBROSIS IN A MYELOFIBROSIS MOUSE MODEL
title_full_unstemmed P999: ERK1/2 INHIBITION REDUCES OSTEOPONTIN PLASMA LEVELS AND BONE MARROW FIBROSIS IN A MYELOFIBROSIS MOUSE MODEL
title_short P999: ERK1/2 INHIBITION REDUCES OSTEOPONTIN PLASMA LEVELS AND BONE MARROW FIBROSIS IN A MYELOFIBROSIS MOUSE MODEL
title_sort p999 erk1 2 inhibition reduces osteopontin plasma levels and bone marrow fibrosis in a myelofibrosis mouse model
url http://journals.lww.com/10.1097/01.HS9.0000846864.95333.42
work_keys_str_mv AT srontauroli p999erk12inhibitionreducesosteopontinplasmalevelsandbonemarrowfibrosisinamyelofibrosismousemodel
AT ebianchi p999erk12inhibitionreducesosteopontinplasmalevelsandbonemarrowfibrosisinamyelofibrosismousemodel
AT ltavernari p999erk12inhibitionreducesosteopontinplasmalevelsandbonemarrowfibrosisinamyelofibrosismousemodel
AT mdallora p999erk12inhibitionreducesosteopontinplasmalevelsandbonemarrowfibrosisinamyelofibrosismousemodel
AT ggrisendi p999erk12inhibitionreducesosteopontinplasmalevelsandbonemarrowfibrosisinamyelofibrosismousemodel
AT mmirabile p999erk12inhibitionreducesosteopontinplasmalevelsandbonemarrowfibrosisinamyelofibrosismousemodel
AT ssartini p999erk12inhibitionreducesosteopontinplasmalevelsandbonemarrowfibrosisinamyelofibrosismousemodel
AT egenovese p999erk12inhibitionreducesosteopontinplasmalevelsandbonemarrowfibrosisinamyelofibrosismousemodel
AT ccarretta p999erk12inhibitionreducesosteopontinplasmalevelsandbonemarrowfibrosisinamyelofibrosismousemodel
AT smallia p999erk12inhibitionreducesosteopontinplasmalevelsandbonemarrowfibrosisinamyelofibrosismousemodel
AT sparenti p999erk12inhibitionreducesosteopontinplasmalevelsandbonemarrowfibrosisinamyelofibrosismousemodel
AT lfabbiani p999erk12inhibitionreducesosteopontinplasmalevelsandbonemarrowfibrosisinamyelofibrosismousemodel
AT nbartalucci p999erk12inhibitionreducesosteopontinplasmalevelsandbonemarrowfibrosisinamyelofibrosismousemodel
AT llosi p999erk12inhibitionreducesosteopontinplasmalevelsandbonemarrowfibrosisinamyelofibrosismousemodel
AT mdominici p999erk12inhibitionreducesosteopontinplasmalevelsandbonemarrowfibrosisinamyelofibrosismousemodel
AT amvannucchi p999erk12inhibitionreducesosteopontinplasmalevelsandbonemarrowfibrosisinamyelofibrosismousemodel
AT rmanfredini p999erk12inhibitionreducesosteopontinplasmalevelsandbonemarrowfibrosisinamyelofibrosismousemodel